Vitrecto 500 mg (Fluralaner SOLUTION) 500 MG

Vitrecto 500 mg is a topical solution containing fluralaner, used for parasitic control in animals. This product is designed for effective parasite management, ensuring the health and well-being of your pets.

Strength

500 MG

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vitrecto 500 mg is primarily used for the treatment and prevention of parasitic infestations in animals. It is applied topically and is effective against a range of parasites, including ticks and fleas. This solution is formulated to provide long-lasting protection, making it a convenient choice for pet owners. What is Vitrecto used for? It is commonly used for parasitic control in pets, ensuring they remain free from common parasites.

Side Effects

When applied as directed, Vitrecto 500 mg works by targeting and eliminating parasites. It is designed to be fast-acting and long-lasting, providing continuous protection. Some pets may experience mild effects such as skin irritation at the application site, which typically subsides quickly.

Precautions & Warnings

Always follow the instructions provided by your veterinarian when using Vitrecto 500 mg. Ensure the solution is applied to a clean, dry area of the skin. Avoid contact with the eyes and mouth of the animal. Store the product in a cool, dry place away from direct sunlight.

Avoid Interactions

Vitrecto 500 mg may interact with other topical treatments or medications. It is important to inform your veterinarian about any other products you are using on your pet. Additionally, avoid using this solution in conjunction with other parasitic control products unless directed by a professional.

Frequently Asked Questions

Vitrecto 500 mg is used for the treatment and prevention of parasitic infestations in animals, including ticks and fleas.

Vitrecto 500 mg should be applied topically to a clean, dry area of the skin, avoiding contact with the eyes and mouth.

Common effects may include mild skin irritation at the application site, which typically subsides quickly.

It is important to consult your veterinarian before using Vitrecto 500 mg with other medications to avoid potential interactions.

Vitrecto 500 mg should be stored in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.